Socio-demographic
|
Female sex1
|
387 (93.3)
|
93 (98.9)
|
294 (91.6)
|
0.009
|
Years of age
|
55 (44.8–61.1)
|
57.8 (50–63)
|
54.3 (42–60)
|
0.001
|
Years of formal education
|
9 (6–13.3)
|
9 (6–12)
|
10 (6–14)
|
0.004
|
Medium-low SE level1
|
388 (93.5)
|
90 (95.7)
|
298 (92.8)
|
0.475
|
RA-related
|
Serum positive RF1
|
373 (89.9)
|
83 (88.3)
|
290 (90.3)
|
0.562
|
Serum positive ACCP1
|
373 (89.9)
|
82 (87.2)
|
291 (90.7)
|
0.334
|
Years of disease duration
|
13.3 (8–18.6)
|
16.6 (12–20)
|
12.5 (7–18)
|
≤ 0.0001
|
Rheumatoid nodes1
|
95 (22.9)
|
49 (63.9)
|
46 (13.6)
|
≤ 0.0001
|
RAPID-3 score
|
4.7 (1.7–11.8)
|
13 (4–17)
|
3.2 (1.4–9)
|
≤ 0.0001
|
High disease activity category1
|
96 (23.1)
|
48 (51.1)
|
48 (15)
|
≤ 0.0001
|
Patient-reported outcomes
|
Pain-VAS
|
5 (2–17.3)
|
14 (5.6–39)
|
4 (1–10)
|
≤ 0.0001
|
Overall disease-VAS
|
5.3 (1–20)
|
16 (5–39)
|
4 (1–16)
|
≤ 0.0001
|
HAQ score
|
0.25 (0–1.13)
|
1.13 (0.13–2)
|
0.13 (0–1)
|
≤ 0.0001
|
SF-36 score
|
71.9 (51.2–86.1)
|
54 (42–78.7)
|
75.5 (58–88)
|
≤ 0.0001
|
Mental component score (SF-36)
|
75 (54.6–88.2)
|
57 (46.8–81)
|
78 (59.4–90)
|
≤ 0.0001
|
Physical component score (SF-36)
|
68.9 (48.9–86.3)
|
47.8 (39–76)
|
75 (54–88.4)
|
≤ 0.0001
|
Comorbidity
|
Presence of comorbidity1
|
255 (61.4)
|
72 (76.6)
|
183 (75)
|
0.001
|
Surgical joint replacement1
|
87 (21)
|
58 (61.7)
|
29 (9)
|
≤ 0.0001
|
Treatment
|
DMARDs/patient
|
1 (1–2)
|
2 (1–2)
|
1 (1–2)
|
0.008
|
Corticosteroids use1
|
182 (43.9)
|
38 (40.4)
|
144 (44.9)
|
0.480
|
Intensive treatment1
|
66 (15.9)
|
19 (20.2)
|
47 (14.6)
|
0.202
|
Compliance with treatment
|
Adherence1
|
227 (54.7)
|
46 (48.9)
|
182 (56.7)
|
0.196
|
Persistence1
|
228 (54.9)
|
41 (43.6)
|
186 (57.9)
|
0.018
|
Concordance1
|
183 (44.1)
|
33 (35.1)
|
150 (46.7)
|
0.058
|
Miscellaneous
|
Health Literacy1
|
329 (79.3)
|
80 (85.1)
|
249 (77.6)
|
0.147
|
Adequate RA knowledge1 (based on CQ)
|
195 (47)
|
31 (33)
|
164 (51)
|
0.002
|
RA family history1
|
186 (44.8)
|
58 (61.7)
|
128 (39.9)
|
≤ 0.0001
|